Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xab8
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Braidwell | 141M | $148M | 0% | Dec 2024 |
|
| Linden Advisors | 56M | $59M | 100% | Dec 2024 |
|
| Graham Capital Management | 56M | $59M | 0% | Dec 2024 |
|
| Wolverine Asset Management | 48M | $50M | 82% | Dec 2024 |
|
| Point72 Asset Management | 38M | $39M | 15% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 38M | $39M | 100% | Dec 2024 |
|
| Advent Capital Management | 35M | $37M | -16% | Dec 2024 |
|
| Weiss Asset Management LP[1 | 33M | $35M | -38% | Dec 2024 |
|
| 683 Capital Management | 25M | $26M | 6% | Dec 2024 |
|
| Lazard Asset Management | 17M | $18M | 0% | Dec 2024 |
|
| State Street Corporation | 13M | $14M | 28% | Dec 2024 |
|
| Polar Capital Holdings | 13M | $13M | 100% | Sep 2024 |
|
| Calamos Advisors | 10M | $11M | 0% | Dec 2024 |
|
| Aristeia Capital | 6.0M | $6.3M | -33% | Dec 2024 |
|
| BlackRock | 5.4M | $5.6M | 23% | Dec 2024 |
|
| New York State Common Retirement Fund | 5.1M | $5.4M | 6% | Dec 2024 |
|
| Jump Financial | 4.0M | $4.2M | -27% | Dec 2024 |
|
| SSI Investment Management | 2.9M | $3.0M | -37% | Dec 2024 |
|
| RWC Asset Management | 2.6M | $2.7M | 0% | Dec 2024 |
|
| CSS | 2.5M | $2.6M | 100% | Dec 2024 |
|
| Wells Fargo & Company | 2.3M | $2.4M | -83% | Dec 2024 |
|
| Man Group | 2.2M | $2.3M | 0% | Dec 2024 |
|
| Axa | 1.6M | $1.7M | 0% | Dec 2024 |
|
| Amundi | 1.5M | $1.6M | 100% | Dec 2024 |
|
| Agf Management | 1.3M | $1.4M | -43% | Dec 2024 |
|
| Bank of America Corporation | 1.2M | $1.2M | 128078% | Dec 2024 |
|
| Royal Bank of Canada | 1.1M | $1.1M | -35% | Dec 2024 |
|
| Palisade Capital Management | 914k | $957k | 0% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 750k | $785k | 100% | Dec 2024 |
|
| Shenkman Capital Management | 540k | $572M | 0% | Dec 2024 |
|
| Toronto-Dominion Bank | 500k | $522k | 100% | Dec 2024 |
|
| Bank of New York Mellon | 300k | $315k | -40% | Dec 2024 |
|
| Russell Investments | 160k | $169k | 0% | Dec 2024 |
|
| Central Pacific Bank - Trust Division | 153k | $160k | -38% | Dec 2024 |
|
| KBC Group NV | 100k | $106k | 0% | Dec 2024 |
|
| First Hawaiian Bank | 45k | $47k | -45% | Dec 2024 |
|
| Rsm Us Wealth Management | 35k | $37k | 21% | Dec 2024 |
|
| Insigneo Advisory Services | 15k | $16k | 7% | Dec 2024 |
|
| Aurum Wealth Management Group | 11k | $12k | 0% | Dec 2024 |
|
| Bank Of Montreal | 3.0k | $3.2k | 0% | Dec 2024 |
|
| Pnc Financial Services | 2.0k | $209k | 100% | Dec 2024 |
|
| Jones Financial Companies, L.L | 1.0k | $1.0k | 100% | Dec 2024 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Balyasny Asset Management | Sep 2024 | 34M | $35M |
| Franklin Resources | Sep 2024 | 2.3M | $2.4M |
| Morgan Stanley | Sep 2024 | 1.6M | $1.6M |
| Oaktree Capital Management | Sep 2024 | 1.2M | $1.3M |
| Invesco | Sep 2024 | 473k | $487k |
| Ubs Global Asset Management Americas | Sep 2024 | 300k | $309k |
| Jpmorgan Chase & Co | Sep 2024 | 44k | $45k |